Literature DB >> 1721254

FK 506: historical perspectives.

T Goto1, T Kino, H Hatanaka, M Okuhara, M Kohsaka, H Aoki, H Imanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721254

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  14 in total

Review 1.  Immunosuppressive drugs in renal transplantation. A review of the regimens.

Authors:  J M Barry
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

2.  Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

3.  A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients.

Authors:  Yan-xia Lu; Qing-hong Su; Ke-hua Wu; Yu-peng Ren; Liang Li; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

Review 4.  Small intestinal transplantation for irreversible intestinal failure in children.

Authors:  S A Kocoshis; J Reyes; S Todo; T E Starzl
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

5.  FK506 (tacrolimus) and its immunoreactive metabolites in whole blood of liver transplant patients and subjects with mild hepatic dysfunction.

Authors:  Y Tokunaga; A M Alak
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 6.  Signaling cascades as drug targets in model and pathogenic fungi.

Authors:  Robert J Bastidas; Jennifer L Reedy; Helena Morales-Johansson; Joseph Heitman; Maria E Cardenas
Journal:  Curr Opin Investig Drugs       Date:  2008-08

Review 7.  Immunosuppression for lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  The diagnosis and management of uveitis.

Authors:  E Anglade; S M Whitcup
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

9.  Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption.

Authors:  M Matsubara; E Yamachika; H Tsujigiwa; N Mizukawa; T Ueno; J Murakami; N Ishida; Y Kaneda; N Shirasu; S Takagi
Journal:  Osteoporos Int       Date:  2009-10-08       Impact factor: 4.507

10.  Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; W Irish; J McMichael; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.